Cargando…
Pretargeted Alpha Therapy of Disseminated Cancer Combining Click Chemistry and Astatine-211
To enhance targeting efficacy in the radioimmunotherapy of disseminated cancer, several pretargeting strategies have been developed. In pretargeted radioimmunotherapy, the tumor is pretargeted with a modified monoclonal antibody that has an affinity for both tumor antigens and radiolabeled carriers....
Autores principales: | Timperanza, Chiara, Jensen, Holger, Bäck, Tom, Lindegren, Sture, Aneheim, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145095/ https://www.ncbi.nlm.nih.gov/pubmed/37111352 http://dx.doi.org/10.3390/ph16040595 |
Ejemplares similares
-
Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure
por: Lindegren, Sture, et al.
Publicado: (2020) -
Astatine-211 based radionuclide therapy: Current clinical trial landscape
por: Albertsson, Per, et al.
Publicado: (2023) -
Automated astatination of biomolecules – a stepping stone towards multicenter clinical trials
por: Aneheim, Emma, et al.
Publicado: (2015) -
Towards elucidating the radiochemistry of astatine – Behavior in chloroform
por: Aneheim, Emma, et al.
Publicado: (2019) -
Evaluation of therapeutic efficacy of (211)At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer
por: Palm, Stig, et al.
Publicado: (2020)